Mesalazine Treatment in IBS (The MIBS Study)

NCT01699438 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

211

Enrollment

OTHER

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: Mesalazine
DRUG: Placebo

Sponsor

Hans Törnblom

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]